Stock HIGH CANTOURAGE GROUP SE
Add to a list
To use this feature you must be a member
Log inSign up

Cantourage Group SE Share Price

Equities

HIGH

DE000A3DSV01

Drug Retailers

Market Closed - Xetra
Other stock markets
 16:36:07 17/05/2024 BST 		5-day change 1st Jan Change
7.25 EUR 0.00% Intraday chart for Cantourage Group SE 0.00% +0.97%
05-14 WDH/Survey: Seven percent of adults have bought cannabis seeds DP
03-27 Cannabis law signed - release on April 1 DP

Financials

Sales 2023 * 23.6M 25.66M 2.02B Sales 2024 * 39.2M 42.61M 3.36B Capitalization 90.41M 98.28M 7.74B
Net income 2023 * -3M -3.26M -257M Net income 2024 * -2M -2.17M -171M EV / Sales 2023 * 3.71 x
Net cash position 2023 * 2.9M 3.15M 248M Net cash position 2024 * 1.9M 2.07M 163M EV / Sales 2024 * 2.26 x
P/E ratio 2023 *
-29 x
P/E ratio 2024 *
-42.6 x
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 99%
More Fundamentals * Assessed data

Chart Cantourage Group SE

Dynamic Chart

Latest news about Cantourage Group SE

WDH/Survey: Seven percent of adults have bought cannabis seeds DP
Cannabis law signed - release on April 1 DP
Controversial cannabis law has been signed DP
TOTAL Federal Council paves the way for growth package and cannabis DP
Federal Council clears the way for cannabis legalization DP
Synbiotic continues to rise after cannabis legalization DP
Circles/Cannabis dispute: Hesse wants to abstain in the Bundesrat DP
Cannabis dispute: Baden-Württemberg in favor of mediation committee DP
Synbiotic corrects after cannabis rally - legalization open DP
Daniel Günther: Cannabis law to be postponed until October DP
Cannabis dispute: Baden-Württemberg calls for mediation committee DP
Cannabis law and clinic atlas in the Bundesrat DP
Dreyer does not expect cannabis law to fail DP
Drugs commissioner lobbies states for cannabis law DP
Union interior ministers want to consider legal action against cannabis legalization DP
More news

Analyst Recommendations on Cantourage Group SE

Synbiotic share price fireworks continue - cannabis approval imminent DP
More recommendations

Press releases Cantourage Group SE

Cantourage : Appropriation of earnings 2023 (in German) PU
Cantourage Group SE records strong growth in revenue and EBITDA in the break-even range in 2023. Strong growth since the partial legalisation of cannabis came into force. EQ
Ad-hoc: Cantourage Group SE records strong growth in 2024 since the partial legalisation of cannabis came into force EQ
Cantourage Group SE records significant revenue growth in the first nine months of 2023 and confirms full-year forecast EQ
Cantourage Group SE: NuWays confirms 'Buy' recommendation EQ
More press releases

News in other languages on Cantourage Group SE

Cantourage Group SE (von Montega AG): Kaufen
Cantourage Group SE (von NuWays AG): Kaufen
Cantourage : Information according to §125 AktG (in German)
Cantourage : Testatsbericht Jahresabschluss zum 31.12.2022
Cantourage : Bericht des Aufsichtsrats
More news

Quotes and Performance

Current month-7.05%
1 month-4.61%
3 months-13.79%
6 months-8.46%
Current year+0.97%
More quotes

Highs and lows

1 week
7.10
Extreme 7.1
7.55
1 month
7.10
Extreme 7.1
8.55
Current year
5.86
Extreme 5.86
11.00
1 year
5.86
Extreme 5.86
13.80
3 years
5.86
Extreme 5.86
40.50
5 years
5.86
Extreme 5.86
40.50
10 years
5.86
Extreme 5.86
40.50
More quotes

Quotes

Date Price Change Volume
17/05/24 7.25 0.00% 960
16/05/24 7.25 -0.68% 8,157
15/05/24 7.3 +2.82% 8,157
14/05/24 7.1 -0.70% 3,701
13/05/24 7.15 -1.38% 1,153

Delayed Quote Xetra, May 17, 2024 at 04:36 pm

More quotes

Company Profile

Cantourage Group SE is a Germany-based holding company. The Company offers products in market segments such as: dried flowers, extracts, Dronabinol and pharma-grade Cannabidiol, through Cantourage GmbH and its subsidiaries. The object of Cantourage GmbH is the production of and wholesale trade in cannabis-based medicinal preparations and trade in other cannabis products.
Sector
Drug Retailers
Calendar
25/06/2024 - Annual General Meeting
More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.25 EUR
Average target price
10 EUR
Spread / Average Target
+37.93%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Cannabis Product Retailers

1st Jan change Capi.
CANTOURAGE GROUP SE Stock Cantourage Group SE
+0.97% 98.29M
GREEN THUMB INDUSTRIES INC. Stock Green Thumb Industries Inc.
+18.70% 3.08B
VERANO HOLDINGS CORP. Stock Verano Holdings Corp.
+18.71% 1.77B
GLASS HOUSE BRANDS INC. Stock Glass House Brands Inc.
+99.79% 678M
TERRASCEND CORP. Stock TerrAscend Corp.
+11.82% 527M
HIGH TIDE INC. Stock High Tide Inc.
+40.38% 174M
MARIMED INC. Stock MariMed Inc.
-8.44% 95.52M
GOLD FLORA CORPORATION Stock Gold Flora Corporation
+46.88% 67.59M
NOVA CANNABIS INC. Stock Nova Cannabis Inc.
+40.45% 57.04M
Cannabis Product Retailers
  1. Stock Market
  2. Equities
  3. HIGH Stock